Heterotopic heart transplantation was initially developed in the laboratory
for experimental transplantation. While it was more widely utilized in the
pre-cyclosporine era to provide adjunct circulatory support in combination
with the native heart, associated complications as well as improved long-t
erm graft survival have now established orthotopic transplantation as the p
rocedure of choice. Heterotopic heart transplantation is currently reserved
for highly selected patients. The technique is only performed at selected
transplantation centers, and indications include significant donor recipien
t size mismatch or irreversible recipient pulmonary hypertension. The fores
eeable introduction of clinical porcine xenotransplantation may lead to ren
ewed interest in the technique of heterotopic heart transplantation as a br
idge to potential native heart recovery or allotransplantation in selected
patients. (C) 2000 Elsevier Science B.V. All rights reserved.